Roche announces collaboration with Atea Pharmaceuticals to develop a potential oral treatment for COVID-19 patients

Media & Investor Release   Roche and Atea partner to jointly develop AT-527, an orally administered direct-acting antiviral (DAA) currently in Phase 2 clinical trials AT-527 has the potential to be the first novel oral antiviral to treat COVID-19 patients outside the hospital setting as well as in the hospital and may also be used in post-exposure

Details

Journey to learn motivates Milica Gavrilović to seek CMP-HC certification

Upon earning her CMP in 2014, Milica says she saw an immediate impact on her skillset and ability to do her job. “It helped me speak with managers from around the world using the same language,” she said. Five years later, she knew that she wanted to continue her learning journey through the CMP-HC curriculum and certification due to the nature of her work with medical professionals.

Details

GO LIVE TOGETHER

ABTS announces its support as a partner for Go LIVE Together, representing over 4,000 companies with U.S. operations—who have joined forces to support legislative actions that will aid the industry’s recovery from COVID-19. The coalition is bound together by the belief that nothing in the world will ever replace the power and need for trade

Details